Conference Insights: Baird's 2017 Global Healthcare Conference

Baird Experts Offer Insights on Healthcare Trends

In conjunction with Baird's 2017 Global Healthcare Conference, Baird experts from across our integrated Healthcare platform provided timely insights on this evolving sector.


Specialization Spurs Evolving Biopharma Landscape

Biotech's research and development focus is shifting toward specialty therapy areas. How can firms differentiate themselves as the sector evolves? Baird Capital discusses the changing market and its recent experience in the space. Learn more.


Charting the Last Mile of Care

Healthcare organizations are looking for clinical workflow and automation technology that translates data into action – and buyers are eager to acquire attractive assets. Baird Global Investment Banking investigates current investment drivers and buyer dynamics. Learn more.

Test Tubes  

What's in Store for Biotech?

After a tough 2016 and amid the ongoing debate over U.S. healthcare legislation, Biotech is on the rebound. Baird's senior research analyst covering Biotech explores the impact of political uncertainty, changes at the FDA and market dynamics in this Q&A. Learn more.